These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3003965)

  • 1. Alteration of in vivo and in vitro effects of heroin by esterase inhibition.
    Gianutsos G; Cohen SD; Carlson G; Heyman R; Salva P; Morrow G; Hite GJ
    Toxicol Appl Pharmacol; 1986 Jan; 82(1):14-8. PubMed ID: 3003965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No heroin or morphine 6beta-glucuronide analgesia in mu-opioid receptor knockout mice.
    Kitanaka N; Sora I; Kinsey S; Zeng Z; Uhl GR
    Eur J Pharmacol; 1998 Aug; 355(1):R1-3. PubMed ID: 9754945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence from opiate binding studies that heroin acts through its metabolites.
    Inturrisi CE; Schultz M; Shin S; Umans JG; Angel L; Simon EJ
    Life Sci; 1983; 33 Suppl 1():773-6. PubMed ID: 6319928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.
    Rossi GC; Brown GP; Leventhal L; Yang K; Pasternak GW
    Neurosci Lett; 1996 Sep; 216(1):1-4. PubMed ID: 8892377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ali-esterase inhibition by tri-ortho-cresyl phosphate.
    MENDEL B; MYERS DK
    Biochem J; 1953 Feb; 53(3):xvi. PubMed ID: 13037662
    [No Abstract]   [Full Text] [Related]  

  • 7. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.
    Schuller AG; King MA; Zhang J; Bolan E; Pan YX; Morgan DJ; Chang A; Czick ME; Unterwald EM; Pasternak GW; Pintar JE
    Nat Neurosci; 1999 Feb; 2(2):151-6. PubMed ID: 10195199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice.
    Rady JJ; Gorny JM; Fujimoto JM
    Jpn J Pharmacol; 1998 Dec; 78(4):443-54. PubMed ID: 9920201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine.
    Selley DE; Cao CC; Sexton T; Schwegel JA; Martin TJ; Childers SR
    Biochem Pharmacol; 2001 Aug; 62(4):447-55. PubMed ID: 11448454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
    Eriksen GS; Andersen JM; Boix F; Bergh MS; Vindenes V; Rice KC; Huestis MA; Mørland J
    J Pharmacol Exp Ther; 2016 Aug; 358(2):209-15. PubMed ID: 27278234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Methoxynaltrexone is not a selective antagonist for the acute psychomotor stimulating effects of heroin and 6-monoacetylmorphine in mice.
    Eriksen GS; Andersen JM; Boix F; Mørland J
    Pharmacol Biochem Behav; 2014 Jul; 122():82-8. PubMed ID: 24699386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice.
    Rady JJ; Aksu F; Fujimoto JM
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1222-31. PubMed ID: 8138935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity.
    Labella FS; Pinsky C; Havlicek V
    Brain Res; 1979 Oct; 174(2):263-71. PubMed ID: 226219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Monoacetylmorphine (6-MAM), Not Morphine, Is Responsible for the Rapid Neural Effects Induced by Intravenous Heroin.
    Perekopskiy D; Kiyatkin EA
    ACS Chem Neurosci; 2019 Aug; 10(8):3409-3414. PubMed ID: 31268284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats.
    Devillers JP; Boisserie F; Laulin JP; Larcher A; Simonnet G
    Brain Res; 1995 Nov; 700(1-2):173-81. PubMed ID: 8624708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat.
    Antonilli L; Petecchia E; Caprioli D; Badiani A; Nencini P
    Psychopharmacology (Berl); 2005 Oct; 182(1):58-64. PubMed ID: 15986196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 3,6-dibutanoylmorphine as an analgesic in vivo: comparison with morphine and 3,6-diacetylmorphine.
    Tasker RA; Nakatsu K
    Life Sci; 1984 Apr; 34(17):1659-67. PubMed ID: 6727542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.
    Walker JR; King M; Izzo E; Koob GF; Pasternak GW
    Eur J Pharmacol; 1999 Oct; 383(2):115-9. PubMed ID: 10585524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of mu-opiate receptors in heroin- and morphine-dependent rats.
    Bolger GT; Skolnick P; Rice KC; Weissman BA
    FEBS Lett; 1988 Jul; 234(1):22-6. PubMed ID: 2839362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation.
    Hubner CB; Kornetsky C
    J Pharmacol Exp Ther; 1992 Feb; 260(2):562-7. PubMed ID: 1738107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.